Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan...

15
・ ・ ・ ・ ・ ・ ・ ・ ・ ・ ・ ・ ・ ・ ・

Transcript of Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan...

Page 1: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty

・ ・ ・・ ・ ・ ・ ・

・ ・ ・・ ・ ・ ・

Page 2: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty
Page 3: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty
Page 4: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty
Page 5: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty
Page 6: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty
Page 7: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty
Page 8: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty
Page 9: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty
Page 10: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty
Page 11: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty
Page 12: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty
Page 13: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty
Page 14: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty
Page 15: Titre de la présentation - eugms. · PDF fileStefania Maggi René Rizzoli9 Avan Aihie Sayer 0 Cornel Sieberll Bruno Vellas12 Matteo Cesari on behalf of ESCEO and the EUGMS frailty

FINAL REPORT HEALTH CARE PROVIDERS - EuGMS · MPI

FINAL REPORT HEALTH CARE PROVIDERS - EuGMS · MPI

THANK YOU FOR YOUR ORDER - ESCEO J...The ICH E7 Question and Answers advocates that it is very important to ensure, to the extent possible, that the population included in the clinical

THANK YOU FOR YOUR ORDER - ESCEO J...The ICH E7 Question and Answers advocates that it is very important to ensure, to the extent possible, that the population included in the clinical

OSTEOARTHRITIS AND HYALURONIC ACID - EuGMS · •Hyaluronic acid (HA) is a natural biological substance, a high-molecular weight glycosaminoglycan • It is a major component of ligament,

OSTEOARTHRITIS AND HYALURONIC ACID - EuGMS · •Hyaluronic acid (HA) is a natural biological substance, a high-molecular weight glycosaminoglycan • It is a major component of ligament,

NWX-FDA OC Moderator: Irene Aihie February 11, … OC Moderator: Irene Aihie 02-11-16/1:00 pm CT Confirmation # 6710051 Page 1 NWX-FDA OC Moderator: Irene Aihie February 11, 2016 1:00

NWX-FDA OC Moderator: Irene Aihie February 11, … OC Moderator: Irene Aihie 02-11-16/1:00 pm CT Confirmation # 6710051 Page 1 NWX-FDA OC Moderator: Irene Aihie February 11, 2016 1:00

14 EuGMS · Spain Carlos Verdejo-Bravo Sweden Peter Johnson Switzerland Rebecca Dreher-Bruggmann The Netherlands Mariëlle Emmelot-Vonk Turkey Mustafa Cankurtaran United Kingdom Tahir

14 EuGMS · Spain Carlos Verdejo-Bravo Sweden Peter Johnson Switzerland Rebecca Dreher-Bruggmann The Netherlands Mariëlle Emmelot-Vonk Turkey Mustafa Cankurtaran United Kingdom Tahir

World Congress on Osteoporosis, Osteoarthritis and ......World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2014): Oral Communication Abstracts

World Congress on Osteoporosis, Osteoarthritis and ......World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2014): Oral Communication Abstracts

NWX HHS FDA Moderator: Irene Aihie October 20, … · guidance document addressing how we would deal ... device type is defined as a grouping of devices that do not ... FDA does not

NWX HHS FDA Moderator: Irene Aihie October 20, … · guidance document addressing how we would deal ... device type is defined as a grouping of devices that do not ... FDA does not

Frailty, Exercise and Nutrition - ESCEO › sites › esceo › ...Med_Frailty_Nutrition.pdf · Frailty may be delayed or even reversed by physical exercise, with or without nutrition

Frailty, Exercise and Nutrition - ESCEO › sites › esceo › ...Med_Frailty_Nutrition.pdf · Frailty may be delayed or even reversed by physical exercise, with or without nutrition

Interpretation and use of FRAX in clinical practice - ESCEO Interprretation... · Interpretation and use of FRAX in clinical practice J. A. Kanis & D. Hans & C. Cooper & S. Baim &

Interpretation and use of FRAX in clinical practice - ESCEO Interprretation... · Interpretation and use of FRAX in clinical practice J. A. Kanis & D. Hans & C. Cooper & S. Baim &

NEWSLETTER - EuGMS · Newsletter: June 2015 Page 2 of 16 Alzheimer Europe 17-18 June: Delegates at Palliare conference take a “Glasgow reak” On 17 and 18 June at the Postgraduate

NEWSLETTER - EuGMS · Newsletter: June 2015 Page 2 of 16 Alzheimer Europe 17-18 June: Delegates at Palliare conference take a “Glasgow reak” On 17 and 18 June at the Postgraduate

Sarcopenia - Esceo

Sarcopenia - Esceo

ESCEO: The European Society for Clinical and Economic ... Markers of bon… · Created Date: 1/5/2011 7:13:25 PM

ESCEO: The European Society for Clinical and Economic ... Markers of bon… · Created Date: 1/5/2011 7:13:25 PM

Taxonomy of rare genetic metabolic bone disorders - ESCEO · Taxonomy of rare genetic metabolic bone disorders ... 12 Laboratory for the Research of Musculoskeletal System, University

Taxonomy of rare genetic metabolic bone disorders - ESCEO · Taxonomy of rare genetic metabolic bone disorders ... 12 Laboratory for the Research of Musculoskeletal System, University

EUGMS EXHIBITOR'S GUIDE 2017 · sociÉtÉ d’exploitation de l’acropolis de nice - service vente exposants 1 esplanade kennedy - bp 4083 - 06302 nice cedex 4 - france ... required

EUGMS EXHIBITOR'S GUIDE 2017 · sociÉtÉ d’exploitation de l’acropolis de nice - service vente exposants 1 esplanade kennedy - bp 4083 - 06302 nice cedex 4 - france ... required

The role of ultrasound in the early assessment of sarcopenia · The role of ultrasound in the early assessment of sarcopenia Stany Perkisas, MD EUGMS, Nice, 21/09/2017

The role of ultrasound in the early assessment of sarcopenia · The role of ultrasound in the early assessment of sarcopenia Stany Perkisas, MD EUGMS, Nice, 21/09/2017

WORLD CONGRESS ON OSTEOPOROSIS, OSTEOARTHRITIS AND ... · malaga, spain 2016 april 14 - 17 wco-iof-esceo 2016 - malaga, spain - programme 2 congress information)ϾÇÍ april 14-17,

WORLD CONGRESS ON OSTEOPOROSIS, OSTEOARTHRITIS AND ... · malaga, spain 2016 april 14 - 17 wco-iof-esceo 2016 - malaga, spain - programme 2 congress information)ϾÇÍ april 14-17,

HOW TO PREVENT - Home - EuGMS · Peterson RC et al. Arch Neurol. 1999;56:303-8. ... (MAPT): a randomised, placebo-controlled trial ... HOW TO PREVENT

HOW TO PREVENT - Home - EuGMS · Peterson RC et al. Arch Neurol. 1999;56:303-8. ... (MAPT): a randomised, placebo-controlled trial ... HOW TO PREVENT

Management of osteoporosis of the oldest old - ESCEO of... · Management of osteoporosis of the oldest old ... tive anti-osteoporosis treatment, ... anti-fracture efficacy requires

Management of osteoporosis of the oldest old - ESCEO of... · Management of osteoporosis of the oldest old ... tive anti-osteoporosis treatment, ... anti-fracture efficacy requires

Nursing Home Research - EuGMS€¦ · Wednesday 2 nd & Thursday 3 rd, December, 2015 • Toulouse France THE CONFERENCE WILL BE HELD AT HOTEL DIEU SAINT JACQUES • 2 RUE VIGUERIE,

Nursing Home Research - EuGMS€¦ · Wednesday 2 nd & Thursday 3 rd, December, 2015 • Toulouse France THE CONFERENCE WILL BE HELD AT HOTEL DIEU SAINT JACQUES • 2 RUE VIGUERIE,

FDA Webinar: Optimizing GUDID Data Quality … Webinar Moderator: Irene Aihie 08-03-17/1:00 pm ET Page 1 . FDA Webinar: Optimizing GUDID Data Quality . Moderator: Irene Aihie . August

FDA Webinar: Optimizing GUDID Data Quality … Webinar Moderator: Irene Aihie 08-03-17/1:00 pm ET Page 1 . FDA Webinar: Optimizing GUDID Data Quality . Moderator: Irene Aihie . August